{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T13:41:44Z","timestamp":1791207704735,"version":"4.1.0"},"reference-count":56,"publisher":"Public Library of Science (PLoS)","issue":"4","license":[{"start":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T00:00:00Z","timestamp":1365552000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0060478","type":"journal-article","created":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T20:45:06Z","timestamp":1365626706000},"page":"e60478","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":106,"title":["Attenuation of Nonsense-Mediated mRNA Decay Enhances In Vivo Nonsense Suppression"],"prefix":"10.1371","volume":"8","author":[{"given":"Kim M.","family":"Keeling","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanying","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivasan","family":"Murugesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Balachandra","family":"Chenna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valery","family":"Belakhov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeyakumar","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadanandan E.","family":"Velu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timor","family":"Baasov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M.","family":"Bedwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"ref1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1002\/wrna.95","article-title":"Suppression of nonsense mutations as a therapeutic approach to treat genetic diseases","volume":"2","author":"KM Keeling","year":"2011","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"ref2","doi-asserted-by":"crossref","first-page":"444","DOI":"10.3109\/10409238.2012.694846","article-title":"Suppression of premature termination codons as a therapeutic approach","volume":"47","author":"KM Keeling","year":"2012","journal-title":"Crit Rev Biochem Mol Biol"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.tig.2008.08.010","article-title":"Introducing sense into nonsense in treatments of human genetic diseases","volume":"24","author":"L Linde","year":"2008","journal-title":"Trends Genet"},{"key":"ref4","doi-asserted-by":"crossref","unstructured":"Keeling KM, Bedwell DM (2010) Recoding therapies for genetic diseases. In: Atkins JF, Gesteland RF, editors. Recoding: Expansion of Decoding Rules Enriches Gene Expression. New York: Springer Publishing.","DOI":"10.1007\/978-0-387-89382-2_6"},{"key":"ref5","unstructured":"Clancy JP, Konstan MW, Rowe SMea (2006) A phase II study of PTC124 in CF patients harboring premature stop mutations. Ped Pulmonol Suppl 41: Abstract 269."},{"key":"ref6","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(08)61168-X","article-title":"Effectiveness of PTC124 treatment of cystic fibrosis caused by nonsense mutations: a prospective phase II trial","volume":"372","author":"E Kerem","year":"2008","journal-title":"Lancet"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S1569-1993(08)60084-3","article-title":"PTC124 induces CFTR full-length production and activity in children with nonsense-mutation-mediated CF","volume":"7","author":"I Sermet-Gaudelus","year":"2008","journal-title":"J Cyst Fibros"},{"key":"ref8","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1183\/09031936.00120910","article-title":"Chronic ataluren (PTC124) treatment of nonsense mutation cystic fibrosis","volume":"38","author":"M Wilschanski","year":"2011","journal-title":"Eur Respir J"},{"key":"ref9","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1002\/ana.22024","article-title":"Gentamicin-induced readthrough of stop codons in Duchenne muscular dystrophy","volume":"67","author":"V Malik","year":"2010","journal-title":"Ann Neurol"},{"key":"ref10","doi-asserted-by":"crossref","first-page":"1262","DOI":"10.1164\/rccm.201001-0137OC","article-title":"Ataluren (PTC124) induces cystic fibrosis transmembrane conductance regulator protein expression and activity in children with nonsense mutation cystic fibrosis","volume":"182","author":"I Sermet-Gaudelus","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"ref11","doi-asserted-by":"crossref","first-page":"S22","DOI":"10.1016\/S1569-1993(08)60085-5","article-title":"PTC124 treatment over 3 months improves pharmacodynamic and clinical parameters in patients with nonsense-mutation-mediated CF","volume":"7","author":"M Wilschanski","year":"2008","journal-title":"J Cyst Fibros"},{"key":"ref12","unstructured":"Konstan M, Accurso F, DeBoeck K, Kerem E, Rowe S, <etal>et al<\/etal>.. (2012) Results of Phase 3 Study of Ataluren in Nonsense Mutation Cystic Fibrosis (nmCF). Abstracts of the European Cystic Fibrosis Conference 2012."},{"key":"ref13","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1172\/JCI28523","article-title":"Nonsense-mediated mRNA decay affects nonsense transcript levels and governs response of cystic fibrosis patients to gentamicin","volume":"117","author":"L Linde","year":"2007","journal-title":"J Clin Invest"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1164\/ajrccm.161.3.9904116","article-title":"A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations","volume":"161","author":"M Wilschanski","year":"2000","journal-title":"Am J Respir Crit Care Med"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1056\/NEJMoa022170","article-title":"Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations","volume":"349","author":"M Wilschanski","year":"2003","journal-title":"N Engl J Med"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1038\/sj.emboj.7601464","article-title":"Structural and functional insights into the human Upf1 helicase core","volume":"26","author":"Z Cheng","year":"2007","journal-title":"EMBO J"},{"key":"ref17","doi-asserted-by":"crossref","first-page":"5477","DOI":"10.1128\/MCB.16.10.5477","article-title":"Genetic and biochemical characterization of mutations in the ATPase and helicase regions of the Upf1 protein","volume":"16","author":"Y Weng","year":"1996","journal-title":"Mol Cell Biol"},{"key":"ref18","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1101\/gad.913001","article-title":"Human SMG-1, a novel phosphatidylinositol 3-kinase-related protein kinase, associates with components of the mRNA surveillance complex and is involved in the regulation of nonsense-mediated mRNA decay","volume":"15","author":"A Yamashita","year":"2001","journal-title":"Genes Dev"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1101\/gad.1389006","article-title":"Binding of a novel SMG-1-Upf1-eRF1-eRF3 complex (SURF) to the exon junction complex triggers Upf1 phosphorylation and nonsense-mediated mRNA decay","volume":"20","author":"I Kashima","year":"2006","journal-title":"Genes Dev"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"3301","DOI":"10.1128\/MCB.22.10.3301-3315.2002","article-title":"Poly(A)-binding protein acts in translation termination via eukaryotic release factor 3 interaction and does not influence [<italic>PSI<\/italic>(+)] propagation","volume":"22","author":"B Cosson","year":"2002","journal-title":"Mol Cell Biol"},{"key":"ref21","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S1097-2765(03)00443-X","article-title":"Phosphorylation of hUPF1 induces formation of mRNA surveillance complexes containing hSMG-5 and hSMG-7","volume":"12","author":"T Ohnishi","year":"2003","journal-title":"Mol Cell"},{"key":"ref22","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/nar\/gkr791","article-title":"N- and C-terminal Upf1 phosphorylations create binding platforms for SMG-6 and SMG-5:SMG-7 during NMD","volume":"40","author":"Y Okada-Katsuhata","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"ref23","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1002\/ana.20107","article-title":"Inhibition of nonsense-mediated mRNA decay rescues the phenotype in Ullrich&apos;s disease","volume":"55","author":"F Usuki","year":"2004","journal-title":"Ann Neurol"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1083\/jcb.200611086","article-title":"Inhibition of nonsense-mediated mRNA decay (NMD) by a new chemical molecule reveals the dynamic of NMD factors in P-bodies","volume":"178","author":"S Durand","year":"2007","journal-title":"J Cell Biol"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/j.ymgme.2011.10.005","article-title":"The designer aminoglycoside NB84 significantly reduces glycosaminoglycan accumulation associated with MPS I-H in the Idua-W392X mouse","volume":"105","author":"D Wang","year":"2012","journal-title":"Mol Genet Metab"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.ymgme.2009.08.002","article-title":"Characterization of an MPS I-H knock-in mouse that carries a nonsense mutation analogous to the human IDUA-W402X mutation","volume":"99","author":"D Wang","year":"2010","journal-title":"Mol Genet Metab"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.molmed.2006.06.001","article-title":"Stop-codon read-through for patients affected by a lysosomal storage disorder","volume":"12","author":"DA Brooks","year":"2006","journal-title":"Trends Mol Med"},{"key":"ref28","first-page":"999","article-title":"Evidence for degradation of mRNA encoding alpha-L-iduronidase in Hurler fibroblasts with premature termination alleles","volume":"40","author":"KP Menon","year":"1994","journal-title":"Cell Mol Biol (Noisy-le-grand)"},{"key":"ref29","first-page":"787","article-title":"Immunoquantification and enzyme kinetics of alpha-L-iduronidase in cultured fibroblasts from normal controls and mucopolysaccharidosis type I patients","volume":"50","author":"LJ Ashton","year":"1992","journal-title":"Am J Hum Genet"},{"key":"ref30","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0925-4439(98)00046-5","article-title":"Genotype-phenotype correlations in mucopolysaccharidosis type I using enzyme kinetics, immunoquantification and <italic>in vitro<\/italic> turnover studies","volume":"1407","author":"S Bunge","year":"1998","journal-title":"Biochim Biophys Acta"},{"key":"ref31","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1355838201000127","article-title":"Evidence that phosphorylation of human Upfl protein varies with intracellular location and is mediated by a wortmannin-sensitive and rapamycin-sensitive PI 3-kinase-related kinase signaling pathway","volume":"7","author":"M Pal","year":"2001","journal-title":"RNA"},{"key":"ref32","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.bbrc.2006.08.017","article-title":"A chemiluminescence-based reporter system to monitor nonsense-mediated mRNA decay","volume":"349","author":"S Boelz","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"ref33","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/1568011043482070","article-title":"Extending nature&apos;s leads: the anticancer agent ellipticine","volume":"4","author":"NC Garbett","year":"2004","journal-title":"Curr Med Chem Anticancer Agents"},{"key":"ref34","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/ng1429","article-title":"Nonsense surveillance regulates expression of diverse classes of mammalian transcripts and mutes genomic noise","volume":"36","author":"JT Mendell","year":"2004","journal-title":"Nat Genet"},{"key":"ref35","doi-asserted-by":"crossref","first-page":"11269","DOI":"10.1073\/pnas.0400541101","article-title":"Reinitiation involving upstream ORFs regulates ATF4 mRNA translation in mammalian cells","volume":"101","author":"KM Vattem","year":"2004","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref36","doi-asserted-by":"crossref","first-page":"6897","DOI":"10.1128\/MCB.18.12.6897","article-title":"Classification of gas5 as a multi-small-nucleolar-RNA (snoRNA) host gene and a member of the 5\u2032-terminal oligopyrimidine gene family reveals common features of snoRNA host genes","volume":"18","author":"CM Smith","year":"1998","journal-title":"Mol Cell Biol"},{"key":"ref37","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1016\/j.bmc.2010.03.060","article-title":"Repairing faulty genes by aminoglycosides: development of new derivatives of geneticin (G418) with enhanced suppression of diseases-causing nonsense mutations","volume":"18","author":"I Nudelman","year":"2010","journal-title":"Bioorg Med Chem"},{"key":"ref38","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1126\/science.1174447","article-title":"A gene network regulating lysosomal biogenesis and function","volume":"325","author":"M Sardiello","year":"2009","journal-title":"Science"},{"key":"ref39","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1038\/ng1403","article-title":"Nonsense-mediated decay approaches the clinic","volume":"36","author":"JA Holbrook","year":"2004","journal-title":"Nat Genet"},{"key":"ref40","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1038\/sj.ejhg.5201649","article-title":"Nonsense-mediated mRNA decay modulates clinical outcome of genetic disease","volume":"14","author":"M Khajavi","year":"2006","journal-title":"Eur J Hum Genet"},{"key":"ref41","first-page":"489","article-title":"The first 5 years of clinical experience with laronidase enzyme replacement therapy for mucopolysaccharidosis I. Expert Opin Pharmacother","volume":"6","author":"JE Wraith","year":"2005"},{"key":"ref42","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1002\/humu.20763","article-title":"A meta-analysis of nonsense mutations causing human genetic disease","volume":"29","author":"M Mort","year":"2008","journal-title":"Hum Mutat"},{"key":"ref43","doi-asserted-by":"crossref","first-page":"12186","DOI":"10.1073\/pnas.1007336107","article-title":"Smg1 is required for embryogenesis and regulates diverse genes via alternative splicing coupled to nonsense-mediated mRNA decay","volume":"107","author":"DR McIlwain","year":"2010","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref44","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/hmg\/10.2.99","article-title":"Rent1, a trans-effector of nonsense-mediated mRNA decay, is essential for mammalian embryonic viability","volume":"10","author":"SM Medghalchi","year":"2001","journal-title":"Hum Mol Genet"},{"key":"ref45","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1101\/gad.468808","article-title":"NMD is essential for hematopoietic stem and progenitor cells and for eliminating by-products of programmed DNA rearrangements","volume":"22","author":"J Weischenfeldt","year":"2008","journal-title":"Genes Dev"},{"key":"ref46","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.gde.2011.03.008","article-title":"Nonsense-mediated mRNA decay (NMD) in animal embryogenesis: to die or not to die, that is the question","volume":"21","author":"J Hwang","year":"2011","journal-title":"Curr Opin Genet Dev"},{"key":"ref47","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1128\/MCB.26.4.1272-1287.2006","article-title":"hUPF2 Silencing Identifies Physiologic Substrates of Mammalian Nonsense-Mediated mRNA Decay","volume":"26","author":"J Wittmann","year":"2006","journal-title":"Mol Cell Biol"},{"key":"ref48","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrg2402","article-title":"The multiple lives of NMD factors: balancing roles in gene and genome regulation","volume":"9","author":"O Isken","year":"2008","journal-title":"Nat Rev Genet"},{"key":"ref49","doi-asserted-by":"crossref","first-page":"10638","DOI":"10.1073\/pnas.1019352108","article-title":"Perturbation of thymocyte development in nonsense-mediated decay (NMD)-deficient mice","volume":"108","author":"PA Frischmeyer-Guerrerio","year":"2011","journal-title":"Proc Natl Acad Sci U S A"},{"key":"ref50","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.molcel.2011.06.031","article-title":"RNA Homeostasis Governed by Cell Type-Specific and Branched Feedback Loops Acting on NMD","volume":"43","author":"L Huang","year":"2011","journal-title":"Mol Cell"},{"key":"ref51","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1261\/rna.030247.111","article-title":"Autoregulation of the nonsense-mediated mRNA decay pathway in human cells","volume":"17","author":"H Yepiskoposyan","year":"2011","journal-title":"RNA"},{"key":"ref52","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1093\/nar\/gkm461","article-title":"The abundance of RNPS1, a protein component of the exon junction complex, can determine the variability in efficiency of the Nonsense Mediated Decay pathway","volume":"35","author":"MH Viegas","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"ref53","doi-asserted-by":"crossref","first-page":"e11657","DOI":"10.1371\/journal.pone.0011657","article-title":"Heritability in the efficiency of nonsense-mediated mRNA decay in humans","volume":"5","author":"C Seoighe","year":"2010","journal-title":"PLoS One"},{"key":"ref54","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1021\/jo01299a028","article-title":"Photocyclization of 1-(1-chloroisoquinolin-6-yl)-1H-v-triazolo[4,5-c]pyridines to 10-chloro-5H-pyrido[3\u20324\u2032:4,5]pyrrolo[isoquinolines (azaellipticines)","volume":"45","author":"C Rivalle","year":"1980","journal-title":"J Org Chem"},{"key":"ref55","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1016\/S0040-4020(01)97964-5","article-title":"11H-Pyrido[3\u2032,2\u2032:4,5]pyrrolo[2,3-g]isoquinoleines (aza-7 ellipticines) substituees sur leur position 6","volume":"37","author":"C Rivalle","year":"1981","journal-title":"Tetrahedron"},{"key":"ref56","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"KJ Livak","year":"2001","journal-title":"Methods"}],"container-title":["PLoS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0060478","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T18:32:50Z","timestamp":1715193170000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0060478"}},"subtitle":[],"editor":[{"given":"David J.","family":"Reiner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":56,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2013,4,10]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0060478","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,10]]}}}